BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36932076)

  • 1. Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome.
    de Jesus AA; Chen G; Yang D; Brdicka T; Ruth NM; Bennin D; Cebecauerova D; Malcova H; Freeman H; Martin N; Svojgr K; Passo MH; Bhuyan F; Alehashemi S; Rastegar AT; Uss K; Kardava L; Marrero B; Duric I; Omoyinmi E; Peldova P; Lee CR; Kleiner DE; Hadigan CM; Hewitt SM; Pittaluga S; Carmona-Rivera C; Calvo KR; Shah N; Balascakova M; Fink DL; Kotalova R; Parackova Z; Peterkova L; Kuzilkova D; Campr V; Sramkova L; Biancotto A; Brooks SR; Manes C; Meffre E; Harper RL; Kuehn H; Kaplan MJ; Brogan P; Rosenzweig SD; Merchant M; Deng Z; Huttenlocher A; Moir SL; Kuhns DB; Boehm M; Skvarova Kramarzova K; Goldbach-Mansky R
    Nat Commun; 2023 Mar; 14(1):1502. PubMed ID: 36932076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid Src-family kinases are critical for neutrophil-mediated autoinflammation in gout and motheaten models.
    Futosi K; Németh T; Horváth ÁI; Abram CL; Tusnády S; Lowell CA; Helyes Z; Mócsai A
    J Exp Med; 2023 Jul; 220(7):. PubMed ID: 37074415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK.
    Kanderova V; Svobodova T; Borna S; Fejtkova M; Martinu V; Paderova J; Svaton M; Kralova J; Fronkova E; Klocperk A; Pruhova S; Lee-Kirsch MA; Hornofova L; Koblizek M; Novak P; Zimmermannova O; Parackova Z; Sediva A; Kalina T; Janda A; Kayserova J; Dvorakova M; Macek M; Pohunek P; Sedlacek P; Poh A; Ernst M; Brdicka T; Hrusak O; Lebl J
    J Allergy Clin Immunol; 2022 Apr; 149(4):1464-1472.e3. PubMed ID: 34536415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role for Lyn kinase in strengthening endothelial integrity and barrier function.
    Han J; Zhang G; Welch EJ; Liang Y; Fu J; Vogel SM; Lowell CA; Du X; Cheresh DA; Malik AB; Li Z
    Blood; 2013 Dec; 122(25):4140-9. PubMed ID: 24108461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration.
    Liu G; Place AT; Chen Z; Brovkovych VM; Vogel SM; Muller WA; Skidgel RA; Malik AB; Minshall RD
    Blood; 2012 Aug; 120(9):1942-52. PubMed ID: 22806890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells.
    Pao LI; Cambier JC
    J Immunol; 1997 Mar; 158(6):2663-9. PubMed ID: 9058799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction.
    Yan M; Zhang X; Chen A; Gu W; Liu J; Ren X; Zhang J; Wu X; Place AT; Minshall RD; Liu G
    FASEB J; 2017 Nov; 31(11):4759-4769. PubMed ID: 28701303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-induced engagement of beta2 integrins in human neutrophils causes a rapid redistribution of cytoskeletal proteins, Src-family tyrosine kinases, and p72syk that precedes de novo actin polymerization.
    Yan SR; Berton G
    J Leukoc Biol; 1998 Sep; 64(3):401-8. PubMed ID: 9738668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
    Congleton J; MacDonald R; Yen A
    Leukemia; 2012 Jun; 26(6):1180-8. PubMed ID: 22182854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-receptor tyrosine kinase Lyn controls neutrophil adhesion by recruiting the CrkL-C3G complex and activating Rap1 at the leading edge.
    He Y; Kapoor A; Cook S; Liu S; Xiang Y; Rao CV; Kenis PJ; Wang F
    J Cell Sci; 2011 Jul; 124(Pt 13):2153-64. PubMed ID: 21628423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Src family tyrosine kinase activities in adherent human neutrophils. Evidence that reactive oxygen intermediates produced by adherent neutrophils increase the activity of the p58c-fgr and p53/56lyn tyrosine kinases.
    Yan SR; Berton G
    J Biol Chem; 1996 Sep; 271(38):23464-71. PubMed ID: 8798554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Novo Gain-Of-Function Variations in LYN Associated With an Early-Onset Systemic Autoinflammatory Disorder.
    Louvrier C; El Khouri E; Grall Lerosey M; Quartier P; Guerrot AM; Bader Meunier B; Chican J; Mohammad M; Assrawi E; Daskalopoulou A; Arenas Garcia A; Copin B; Piterboth W; Dastot Le Moal F; Karabina SA; Amselem S; Giurgea I
    Arthritis Rheumatol; 2023 Mar; 75(3):468-474. PubMed ID: 36122175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory effect of 2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol by targeting Lyn kinase in human neutrophils.
    Liao HR; Chien CR; Chen JJ; Lee TY; Lin SZ; Tseng CP
    Chem Biol Interact; 2015 Jul; 236():90-101. PubMed ID: 25980585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera.
    Nagao T; Kurosu T; Umezawa Y; Nogami A; Oshikawa G; Tohda S; Yamamoto M; Miura O
    PLoS One; 2014; 9(1):e84746. PubMed ID: 24404189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.
    Mahon FX; Hayette S; Lagarde V; Belloc F; Turcq B; Nicolini F; Belanger C; Manley PW; Leroy C; Etienne G; Roche S; Pasquet JM
    Cancer Res; 2008 Dec; 68(23):9809-16. PubMed ID: 19047160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
    Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
    Schwarz LJ; Fox EM; Balko JM; Garrett JT; Kuba MG; Estrada MV; González-Angulo AM; Mills GB; Red-Brewer M; Mayer IA; Abramson V; Rizzo M; Kelley MC; Meszoely IM; Arteaga CL
    J Clin Invest; 2014 Dec; 124(12):5490-502. PubMed ID: 25401474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration.
    Allingham MJ; van Buul JD; Burridge K
    J Immunol; 2007 Sep; 179(6):4053-64. PubMed ID: 17785844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib.
    Gleixner KV; Mayerhofer M; Cerny-Reiterer S; Hörmann G; Rix U; Bennett KL; Hadzijusufovic E; Meyer RA; Pickl WF; Gotlib J; Horny HP; Reiter A; Mitterbauer-Hohendanner G; Superti-Furga G; Valent P
    Blood; 2011 Aug; 118(7):1885-98. PubMed ID: 21680801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.